Authors
Latest:
Assessing the Impact of Patient Assistance Programs on Financial Toxicity in Oral OncologyPAPs can significantly reduce OOP costs for patients.
Latest:
The Ethics and Economics of California’s End of Life Option ActIn addition to moral arguments, economic issues must be considered.
Latest:
Implementing CDC’s Core Elements of SepsisThe agency outlines key elements for building effective hospital sepsis programs.
Latest:
Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia TreatmentBRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
Latest:
Current Drug Pathways in Non–Small Cell Lung CancerAdvancements in genomic and mutational analysis show that up to 60% of adenocarcinomas and up to 50% to 80% of squamous cell carcinomas (SCC) have a known oncogenic driver mutation.
Latest:
Five Fast Facts About IVIGBy functioning as an antibody replacement therapy, IVIG can be used to manage a wide range of inflammatory and autoimmune disorders.
Latest:
How 2023 Can Be the Year of Clinical PharmacogenomicsIn terms of science and technology, the health care community has everything needed to clinically implement pharmacogenomics testing.
Latest:
Dengue Vaccine: What Pharmacists Need to KnowThe FDA approved the first vaccine for dengue disease in May 2019.
Latest:
Offering Specialty Infusions May Be Worth the Work for Oncology PracticesExpanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.
Latest:
Driving Patient Safety With New Pharmacy HIT StandardsNew standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.
Latest:
Multiple Myeloma Therapy Often Causes Cardiovascular ComplicationsMany patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
Latest:
Emerging Bispecific T-Cell Engagers in Myeloma: Promises and HurdlesThe multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
Latest:
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing SarcomaThis retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Latest:
Recognize the Value of Health Care VolunteersThe health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Latest:
How to Create an Inclusive Culture for LGBTQ+ Patients at the Pharmacy: A Practical ApproachFacilitating environmental cues that members of the LGBTQ+ community look for to signify that they are in a safe space is an especially important element for the LGBTQ+ community.
Latest:
The Expanding Role of CDK 4/6 Inhibitors in Breast Cancer TreatmentCyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.
Latest:
Clinical Overview: Dapagliflozin for Patients with Heart Failure, Reduced Ejection Fraction and Preserved Ejection FractionManagement of heart failure focuses on avoiding reversible precipitants and optimizing guideline-directed therapy to lower mortality and hospitalizations.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Latest:
Semaglutide and Cardiovascular Risk Reduction: What the Latest Data Tell UsJohn Buse, MD, PhD discusses the expanding role of GLP-1 receptor agonists in treatment of cardiovascular conditions.
Latest:
Extemporaneous Compounding of Amoxicillin Suspensions During National ShortageAs of November 2022, amoxicillin suspension has been on a national shortage list, therefore the FDA has permitted temporary compounding of amoxicillin suspensions.
Latest:
Holistic Psoriatic Arthritis Care: Why Well-Being Should Be Incorporated Into the Treatment ParadigmPeople living with psoriatic arthritis deserve to be informed about ways to approach disease management holistically and with a personalized approach.
Latest:
Pharmacies Poised to Capture At-Home Diagnostics CategoryBy leveraging do-it-yourself testing momentum, community-based and retail pharmacies can solidify their position as health care hubs with a category management approach that enhances the consumer experience and boosts store relevance and revenue.
Latest:
Sharita Howe, PharmD, on Leadership, Pharmacy, and Innovation: ‘Pharmacists Are Like Superheroes, We Can Do Anything’Sharita Howe, PharmD, discusses her recent acknowledgement by MM+M, who acknowledged her as a part of the next wave of health care leaders in their recognition of 40 under 40 leaders in health care.
Latest:
Study Highlights Pharmacy Student Perspective on Mental Health, Future PracticePharmacy programs are implementing new practices into their curriculum and research is being focused on mental health care.
Latest:
Applying an Error Prevention Process to a COVID-19 Vaccination ClinicAn overview for community pharmacies of a process to minimize vaccine errors using a COVID-19 vaccine point of distribution as an example.
Latest:
Insight: Pharmacists Play Key Role in Educating Patients With CKD on Semaglutide Use, ManagementAccording to Pranav Garimella, pharmacists are essential in counseling patients with CKD on the appropriate use of semaglutide.
Latest:
Vaccinations in the Emergency Department: Current and Emerging Practices to Boost Public HealthPiloting new emergency department-based vaccination campaigns and fine-tuning existing programs may reduce morbidity and mortality associated with vaccine-preventable diseases.
Latest:
The Evolving Role of Adjuvant Immunotherapy in Resected Renal Cell Carcinoma: Key Findings and Future DirectionsThe adjuvant therapy has demonstrated varied efficacy for patients.
Latest:
A Primer for Medical Specialty Drug Utilization Management StrategiesCase management programs or pharmacist-delivered high-touch care are critical components in medical specialty drug management.
